Mar 31, 2012
1. COPORATE INFORMATION
Anu's Laboratories Limited is one of the leading manufacturers of 2,4-
Dichloro-5 Fluro Acetophenone, CSI Hydroxy Lactum, Chlorohexanone
2-one, Q-acid, Sodium Methoxide solution and powder. Anu's Laboratories
Limited has manufacturing facilities at Shad Nagar, Isnapur,
Visakapatnam and Pydibhimavaram in Andhra Pradesh.
The financial statements of the Company are prepared on accrual basis.
2.1 Long-term loan from bank: The loan from ING Vysya Bank Limited is
secured by way of exclusive first charge on fixed assets of the Company
situated at Jawaharlal Nehru Pharma City, Parwada, Vizag. This facility
is further secured by way of pari pasu first charge on all other fixed
assets of the Company, both present & future, along with other term
lenders. The loan is repayable in 12 quarterly installments and the
last being October 2014 and carries rate of interest of 16%.
2.2 Long-term loan from others: The loan from IFCI Venture Capital
Funds Limited and is secured by way of exclusive first charge on fixed
assets of the Company situated at Pydibhimavaram, Srikakulam District,
Andhra Pradesh. This facility is secured by way of pledge of shares of
promoters of the Company and also guaranteed by the Managing Director
of the Company. The loan is repayable in 9 quarterly installments and
the last installment being in January 2014 and carries rate of interest
of 16%.
2.3 Finance lease obligations are secured against leased assets (Refer
Note 13.1).
2.4 Unsecured loan: The long term unsecured loan of Rs.170.00 million
from Shri Ram City Union Finance Limited secured against personal
property of the promoters and repayable in one year and carrying rate
of interest @ 24% p.a.
2.5 The working capital facilities are sanctioned by IDBI, State Bank
of India, ING Vysya Bank and Karur Vysya Bank. These facilities are
secured by first charge on all the current assets, both present &
future. There are further secured by way of second charge on the
immovable properties of the Company. These are further secured by way
of paripassu first charge on the properties belongs to the promoters &
relatives of the promoters and also guaranteed by the Promoter
Directors and Directors of the Company. These loans are payable on
demand and carry average rate of interest 15% p.a.
3. General description of lease terms
a. Lease rentals are charges on the basis of agreed terms
b. Assets are taken on lease for a period of five years
4. CONTINGENT LIABILITIES
Particulars 2011-12 2010-11
a. Bank guarantees & letter of
credit given by banks 11.67 413.98
b. Details of statutory authorities
disputed by the Company in appeals
with higher authorities in respect of:
Disputed sales tax demands
A.Y. 2001-02 1.00 1.00
A.Y. 2003-04 0.68 0.68
A.Y. 2004-05 1.82 1.82
A.Y. 2005-06 2.21 2.21
c. Other legal claims
M/s. Sun Moon Chemicals Private Limited
filled a suit against the Company for a
demand of Rs.4.68 million. 4.68 4.68
Total 22.06 424.37
5. SEGMENT REPORTING
a. Company's operations are predominantly related to the manufacture
of bulk drugs intermediates, as such there is only one primary
reportable segment. Secondary reportable segments are identified taking
into account the geographical markets available to the products, the
differing risks, returns and internal reporting system.
b. As a part of secondary reporting, revenues are attributed to
geographical areas based on the location of customers as detailed
below:
6. REGROUPED
Previous year's figures have been regrouped/reclassified wherever
necessary, to confirm to the current year classification.
Mar 31, 2011
1. SEGMENT REPORTING
a. Company's operations are predominantly related to the manufacture of
bulk drugs intermediates, as such there is only one primary reportable
segment. Secondary reportable segments are identified taking into
account the geographical markets available to the products, the
differing risks, returns and internal reporting system.
2. Related Party Transactions
Disclosures as required by the Accounting Standard -18 are given below:
a. Name of the related parties and descriptions of relationships
Name Nature of relationship
M/s. Sambasiva Transport Associate
b. Key Managerial Personnel
Mr. K. Hari Babu, Managing Director
Mr. M.S.S.V. Satyanarayana, Wholetime Director
3. Employee Benefits
a. Defined Contribution Plan
The Company's Employee's Provident Fund administered through Government
Provident Fund, Employees State Insurance Scheme and labor Welfare Fund
are considered as Defined Contribution Plans. The Company's
contributions paid/payable towards these defined contributions plan are
recognized as expense in the Profit 'and Loss Account during the period
in which the employee renders the related service. The provident fund
scheme additionally requires the company to guarantee payment of
interest at rates notified by the central government from time to time.
The Company has recognized Rs.6.53 million (Previous year: Rs.3.39
million) for provident fund contributions & ESI Contributions in the
Profit and Loss Account. The contributions payable to these plans by
the Company are at rates specified in the rules of the schemes.
b. Defined Benefit Plan
Company's liabilities towards gratuity, long term compensated absences
are considered as Defined Benefit Plans. The present value of the
obligations under such Defined Benefit Plans are determined based on
actuarial valuation using the projected unit credit method, which
recognizes each period of service as giving rise to an additional unit
of employee benefit entitlement and measures each unit separately to
build up the final obligation. Actuarial gains and losses are
recognized immediately in the statement of profit and loss. The
obligation is measured at the present value of estimated future cash
flows using a discount rate that is determined by reference to market
yields at the Balance Sheet date on government securities.
4. Disclosure Required by Micro, Small and Medium Enterprises
(Development) Act, 2006
In the absence of necessary information relating to the suppliers
registered as micro or small enterprises under the Micro, Small and
Medium Enterprises (Development) Act, 2006 the Company has not been
able to identify such suppliers and the information required under the
said Act could not be compiled and disclosed.
5. Contingent Liabilities not provided for
Rs. Million
March 31, 2011 March 31, 2010
a. Unexpired bank guarantees 413.99 105.75
& Letters of Credit
b. Demands of statutory
authorities disputed by the
Company in appeals with higher
authorities in respect of
i. Disputed Income Tax A.Y. 2004-05 Ã 0.27
ii. Disputed Sales Tax demands
A.Y. 2001-02 1.00 1.00
A.Y. 2003-04 0.68 0.67
A.Y. 2004-05 1.83 1.83
A.Y. 2005-06 2.21 2.21
c. Other legal claims
M/s. Sun Moon Chemicals 4.68 4.68
Private Limited filed a suit
against the Company for a
demand of Rs.4.68 million.
6. Confirmation of balance
In respect of some of the sundry debtors, creditors, loans, advances &
other receivables confirmation of balances yet to be received.
7. A. Production Data
Note: a. Including contract manufacturing and purchases of finished
goods.
b. Installed capacity is flexible as the plant is versatile; enabling
the Company to produce in different capacities and therefore it varies
depending on the product programmed.
D. Earnings in foreign currency
Export of goods on FOB basis Rs.358.73 million (Previous year:
Rs.298.68 million).
8. Events subsequent to the date of the Balance Sheet
Pursuant to the amalgamation of Nitya Laboratories Limited, the figures
of current year are not strictly comparable to those of the previous
year. Previous year's figures have been regrouped/reclassified wherever
necessary, to conform to current year classification.
Mar 31, 2010
1. Contingent liabilities
Contingent liabilities are disclosed after careful examination of the
facts and legal aspects of the matter involved.
2. SEGMENT REPORTING
a. Companys operations are predominantly related to the manufacture of
bulk drugs intermediates, as such there is only one primary reportable
segment. Secondary reportable segments are identified taking into
account the geographical markets available to the products, the
differing risks, returns and internal reporting system.
3. Related Party Transactions
Disclosures as required by the Accounting Standard -18 are given below:
4. Employee Benefits
a. Defined Contribution Plan
The Companys Employees Provident Fund administered through Government
Provident Fund, Employees State Insurance Scheme and Labor Welfare Fund
are considered as Defined Contribution Plans. The Companys
contributions paid/payable towards these defined contributions plan are
recognized as expense in the Profit and Loss Account during the period
in which the employee renders the related service. The interest rate
payable by the trust to the beneficiaries every year is being notified
by the government. The Company has no obligation to make good the
shortfall, if any, between the return from the investments and the
notified interest rate.
b. Defined Benefit Plan
Companys liabilities towards gratuity are considered as defined
benefit plan. The present value of the obligation under such defined
benefit plan is determined based on actuarial valuation.
5. Disclosure Required by Micro, Small and Medium Enterprises
(Development) Act, 2006
In the absence of necessary information relating to the suppliers
registered as Micro or Small enterprises Under the- Micro, Small and
Medium Enterprises (Development) Act, 2006, the Company has not been
able to Identify such suppliers and the information required under the
said Act could not be compiled and disclosed.
6. Deferred Tax
The Company has been recognizing in the financial statements the
deferred tax assets/liabilities, in accordance with Accounting Standard
22 - Accounting for Taxes on Income issued by the Institute of
Chartered Accountants of India. The position of Deferred Tax Assets
and liabilities is as fallows:
7. Confirmation of balance
In respect of some of the sundry debtors, creditors, loans, advances &
other receivables confirmation of balances yet to be received.
8. A. Production Data
Installed capacity, actual production
Note: a. Includes contract manufacturing and purchases of finished
goods.
b. Installed capacity is flexible as the plant is versatile, enabling
the Company to produce in different capacities and therefore it varies
depending on the product programmed.
9. Events subsequent to the date of the Balance Sheet
The Board of Directors has approved the merger of M/s. Nitya
Laboratories Limited with the Company and the effective date is from
April 1, 2009. The Company has filed an application with the Honble
High Court for necessary approval. The Honble High Court has admitted
the application and called for a meeting of equity shareholders on May
29, 2010 and the process is under progress.
10. Previous years figures have been regrouped and/or rearranged
wherever necessary.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article